Outside advisers to the US Food and Drug Administration have recommended relaxing restrictions on a series of popular peptide compounds sought after in wellness circles. The advisory panel delivered its recommendations following
More
The first half of 2026 has seen active U.S. Food and Drug Administration enforcement activity spanning multiple regulatory domains affecting businesses across sectors. Legal experts are urging in-house counsel to closely monitor
More
The US Court of Appeals for the Tenth Circuit has affirmed in part and reversed in part the dismissal of a false advertising complaint involving two rival pet food companies. The case,
More
The final week of July is widely regarded as one of the most gruelling periods in any aspiring lawyer’s professional life. Known informally among the legal community as Hell Week, the bar
More
The American Association of Law Libraries has wrapped up its annual conference in Cleveland, Ohio, the home of the Rock and Roll Hall of Fame. The gathering drew professionals from across the
More
3i Group (LSE: III) shares climbed another 6% on Wednesday as the FTSE 100 private equity investment trust continued its recent recovery. The jump followed a strong first-quarter update from Action, the
More
London’s FTSE 100 index traded in muted territory as losses among mining stocks weighed against stronger performance from energy companies during the session. The blue-chip index struggled to find clear direction, with
More
Brent crude oil prices have surged past $100 per barrel, dealing a significant early blow to Prime Minister Andy Burnham’s flagship cost of living programme. The benchmark price crossed the $100 milestone
More
Johnson & Johnson has reported strong phase 3 results combining its bispecific antibody Talvey with Darzalex Faspro in earlier-stage multiple myeloma patients. The data emerged from J&J’s MonumenTAL-3 phase 3 study, which
More
Cardinal Health (NYSE: CAH) has announced two definitive agreements totalling approximately $360 million in cash to expand its at-Home Solutions division. The company is acquiring the Diabetes Health business of AdaptHealth Corp.
More